Platelet Indices and Their Role in Gestational Diabetes Mellitus and Pre-Eclampsia: A Comparative Study
DOI:
https://doi.org/10.21276/apalm.3723Keywords:
diabetes, gestational, pre-eclampsia, platelet count, platelet activation, neutrophil-lymphocyte ratioAbstract
Background: Gestational diabetes mellitus (GDM) and pre-eclampsia (PE) are common pregnancy complications linked to significant maternal and perinatal morbidity. Both conditions involve platelet activation and systemic inflammation, making platelet indices potential markers for early diagnosis and monitoring.
Methods: This comparative study involved 180 pregnant women divided equally into three groups: newly diagnosed PE, newly diagnosed GDM, and healthy controls. Participants were recruited at LNJP Hospital, New Delhi. Platelet indices including platelet count, mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit, platelet large cell ratio (P-LCR), platelet-lymphocyte ratio (PLR), and neutrophil-lymphocyte ratio (NLR) were measured using a hematology analyzer. Statistical analysis was conducted using one-way ANOVA with post-hoc Tukey test to compare groups.
Result: Significant alterations in platelet indices were observed in both GDM and PE groups compared to controls (p < 0.001). MPV, PDW, P-LCR, PLR, and NLR levels were elevated in GDM and PE, with the highest values in PE. Platelet count and plateletcrit were notably reduced, especially in PE. These findings indicate enhanced platelet activation and systemic inflammation in these conditions.
Conclusion: Platelet indices demonstrate significant changes in GDM and PE, reflecting their role in the pathogenesis of these disorders. Given their accessibility through routine blood tests, these indices offer cost-effective, non-invasive tools for early risk assessment and monitoring. Further large-scale studies are recommended to validate their clinical utility.
References
1. Onisai M, Vladareanu AM, Bumbea H, Ciorascu M, Pop C, Andrei C, et al. A study of the hematological picture and of platelet function in preeclampsia-report of a series of cases. Maedica. 2009;4(4):[online].
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2020;43(Suppl 1):S14–31.
3. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations. Diabetes Care. 2010;33(3):676–82.
4. Roberts JM, Hubel CA. The two stage model of preeclampsia. Placenta. 2009;30:S32–7.
5. Redman CW, Sargent IL. Immunology of preeclampsia. Am J Reprod Immunol. 2010;63(6):534–43.
6. Mutua D, Nyaga E, Njagi M, Orinda G. Hematological profile of normal pregnant women. J Blood Lymph. 2018;8(2):1–6.
7. Vizioli L, Muscari S, Muscari A. The mean platelet volume. Thromb Haemost. 2009;102(4):711–8.
8. Çintesun E, Çintesun FN, Ezveci H, Akyürek F, Çelik Ç. Systemic inflammatory markers in preeclampsia. J Lab Physicians. 2018;10(3):316–9.
9. Sahbaz A, Cicekler H, Aynioglu O, Isik H, Ozmen U. Plateletcrit and other parameters in gestational diabetes. J Obstet Gynaecol. 2016;36(5):589–93.
10. Yılmaz ZV, Yılmaz E, İçer B, Küçüközkan T. Association of complete blood count parameters with GDM. Gynecol Obstet Reprod Med. 2017;23(2):65–9.
11. Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. Platelet indices and preeclampsia. Hematol Transfus Cell Ther. 2019;41:129–33.
12. Sitotaw C, Asrie F, Melku M. Platelet and white cell parameters in preeclampsia. Pregnancy Hypertens. 2018;13:242–7.
13. Hessami K, Tabrizi R, Homayoon N, Hashemi A, Heydari ST, Pourhoseini SA. PLR and NLR in GDM: a meta-analysis. Biomarkers. 2021;26(6):491–8.
14. Huang Y, Chen X, You ZS, Gu F, Li L, Wang D, et al. Platelet parameters in predicting GDM. J Matern Fetal Neonatal Med. 2022;35(11):2031–5.
15. Salama HF, Antar ME, Dayer MZ. Blood indices and severity of preeclampsia. Egypt J Hosp Med. 2022;87(1):1939–43.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pooja Rani, Deepika Rani, Rashmi Jain Gupta, Deepti Goswami
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
